Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor Conferences
Gilead Sciences (Nasdaq: GILD) executives will speak at five investor conferences during November and December 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
- Wolfe Research Healthcare Conference on Tuesday, November 10 at 11:20 AM Eastern Time
- UBS Global Biopharma Conference on Tuesday, November 17 at 10:00 AM Greenwich Mean Time
- Jefferies Global Healthcare Conference on Tuesday, November 17 at 2:30 PM Greenwich Mean Time
- Citi’s Global Healthcare Conference on Tuesday, December 1 at 11:00 AM Eastern Time
- Annual Evercore Healthcare Conference on Wednesday, December 2 at 11:40 AM Eastern Time
The live webcasts can be accessed on the company’s investor relations website at investors.gilead.com. The replays will be available for at least 30 days following each presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261030499668/en/
Jacquie Ross, CFA – Investors
investor_relations@gilead.com
Source: Gilead Sciences, Inc.